Commonwealth Equity Services’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-12
| Closed | -$4K | – | 3903 |
|
2023
Q3 | $4K | Hold |
12
| – | – | ﹤0.01% | 3807 |
|
2023
Q2 | $9K | Hold |
12
| – | – | ﹤0.01% | 3794 |
|
2023
Q1 | $7 | Hold |
12
| – | – | ﹤0.01% | 3734 |
|
2022
Q4 | $9K | Hold |
12
| – | – | ﹤0.01% | 3650 |
|
2022
Q3 | $19K | Hold |
12
| – | – | ﹤0.01% | 3584 |
|
2022
Q2 | $14K | Hold |
12
| – | – | ﹤0.01% | 3601 |
|
2022
Q1 | $20K | Sell |
12
-74
| -86% | -$123K | ﹤0.01% | 3658 |
|
2021
Q4 | $221K | Buy |
+86
| New | +$221K | ﹤0.01% | 3216 |
|